Literature DB >> 27315446

Beyond Prostate Adenocarcinoma: Expanding the Differential Diagnosis in Prostate Pathologic Conditions.

Yi Li1, John Mongan1, Spencer C Behr1, Seema Sud1, Fergus V Coakley1, Jeffry Simko1, Antonio C Westphalen1.   

Abstract

Recent advances in magnetic resonance (MR) imaging of the prostate gland have dramatically improved the ability to detect and stage adenocarcinoma of the prostate, one of the most frequently diagnosed cancers in men and one of the most frequently diagnosed pathologic conditions of the prostate gland. A wide variety of nonadenocarcinoma diseases can also be seen with MR imaging, ranging from benign to malignant diseases, as well as infectious and inflammatory manifestations. Many of these diseases have distinctive imaging features that allow differentiation from prostate acinar adenocarcinoma. Early recognition of these entities produces a more accurate differential diagnosis and may enable more expeditious clinical workup. Benign neoplasms of the prostate include plexiform neurofibroma and cystadenoma, both of which demonstrate distinctive imaging features. Stromal neoplasms of uncertain malignant potential are rare tumors of uncertain malignant potential that are often difficult to distinguish at imaging from more-malignant prostate sarcomas. Other malignant neoplasms of the prostate include urothelial carcinoma, primary prostatic carcinoid, carcinosarcoma, endometrioid or ductal adenocarcinoma, and mucinous adenocarcinoma. Prostatic infections can lead to abscesses of pyogenic, tuberculous, or fungal origins. Finally, miscellaneous idiopathic disorders of the prostate include amyloidosis, exophytic benign prostatic hyperplasia, and various congenital cysts. Considerable overlap can exist in the clinical history and imaging findings associated with these prostate pathologic conditions, and biopsy is often required for ultimate confirmation of the diagnosis. However, many diagnoses, including cystadenoma, mucinous adenocarcinoma, sarcoma, and abscesses, have distinct imaging features, which can enable the informed radiologist to identify the diagnosis and recommend appropriate clinical workup and management. (©)RSNA, 2016.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27315446     DOI: 10.1148/rg.2016150226

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  10 in total

1.  The Influence of Background Signal Intensity Changes on Cancer Detection in Prostate MRI.

Authors:  Andreas M Hötker; Evelyn Dappa; Yousef Mazaheri; Behfar Ehdaie; Junting Zheng; Marinela Capanu; Hedvig Hricak; Oguz Akin
Journal:  AJR Am J Roentgenol       Date:  2019-02-04       Impact factor: 3.959

2.  Perspective: a critical assessment of PI-RADS 2.1.

Authors:  T Ullrich; L Schimmöller
Journal:  Abdom Radiol (NY)       Date:  2020-12

3.  Magnetic resonance imaging findings of pure prostatic ductal adenocarcinomas: a case series.

Authors:  Hiromi Edo; Yasuyo Urase; Yoshiko Ueno; Ayumu Kido; Tsutomu Tamada; Yudai Asano; Kentaro Ida; Hisataka Ito; Takashi Koyama; Kosuke Miyai; Hitoshi Tsuda; Hiroshi Shinmoto
Journal:  Abdom Radiol (NY)       Date:  2022-02-28

Review 4.  Imaging of non-epithelial neoplasms of the prostate.

Authors:  Pankaj Nepal; Arpit Nagar; Sree Harsha Tirumani; Vijayanadh Ojili
Journal:  Abdom Radiol (NY)       Date:  2020-09-22

Review 5.  [Multiparametric MRI of the prostate : Important radiological findings for urologists].

Authors:  Heinz-Peter Schlemmer
Journal:  Radiologe       Date:  2017-08       Impact factor: 0.635

6.  Robotic approach to Giant multiloculated cystadenoma of the prostate: Initial experience.

Authors:  William C Daly; Jessica A Mandeville; Bruce Tronic; Alireza Moinzadeh
Journal:  Urol Case Rep       Date:  2021-04-25

7.  68Ga-PSMA-11 PET/CT for prostate cancer staging and risk stratification in Chinese patients.

Authors:  Shiming Zang; Guoqiang Shao; Can Cui; Tian-Nv Li; Yue Huang; Xiaochen Yao; Qiu Fan; Zejun Chen; Jin Du; Ruipeng Jia; Hongbin Sun; Zichun Hua; Jun Tang; Feng Wang
Journal:  Oncotarget       Date:  2017-02-14

8.  Case Report: Prostate Adenocarcinoma With Mucinous Features of Normal-Level Serum PSA, Atypical Imaging, Biopsy-Negative, and Peculiar Urethrocystoscopic Manifestation.

Authors:  Yao Zhang; Hua Shen; Kai Liao; Weili Wu; Jiuming Li; Hongbo Yu; Hongfei Wu; Zengjun Wang
Journal:  Front Oncol       Date:  2020-12-23       Impact factor: 6.244

9.  Magnetic Resonance Imaging-Guided Confirmatory Biopsy for Initiating Active Surveillance of Prostate Cancer.

Authors:  Rajiv Jayadevan; Ely R Felker; Lorna Kwan; Danielle E Barsa; Haoyue Zhang; Anthony E Sisk; Merdie Delfin; Leonard S Marks
Journal:  JAMA Netw Open       Date:  2019-09-04

Review 10.  Differential diagnosis of uncommon prostate diseases: combining mpMRI and clinical information.

Authors:  Chao Han; Lina Zhu; Xiang Liu; Shuai Ma; Yi Liu; Xiaoying Wang
Journal:  Insights Imaging       Date:  2021-06-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.